Asset Allocation

As of July 31, 2026.
Type % Net
Cash 23.61%
Stock 54.07%
Bond 15.07%
Convertible 0.00%
Preferred 0.00%
Other 7.25%
View Asset Allocation
Start Trial

Market Capitalization

As of July 31, 2026
Large 100.0%
Mid 0.00%
Small 0.00%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 44.95%    % Emerging Markets: 24.19%    % Unidentified Markets: 30.86%

Americas 25.28%
15.07%
United States 15.07%
10.20%
Brazil 7.21%
Chile 0.57%
Colombia 0.30%
Mexico 2.12%
As of July 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.27%
United Kingdom 0.00%
2.75%
Ireland 2.07%
Switzerland 0.68%
0.00%
1.52%
South Africa 1.52%
Greater Asia 39.59%
Japan 0.00%
0.00%
27.13%
Hong Kong 9.02%
Singapore 0.85%
South Korea 3.27%
Taiwan 13.99%
12.47%
China 5.72%
India 6.54%
Indonesia 0.20%
Unidentified Region 30.86%

Bond Credit Quality Exposure

AAA 0.00%
AA 7.90%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 92.10%
Short Term 0.00%
As of July 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
49.41%
Materials
7.41%
Consumer Discretionary
24.13%
Financials
17.31%
Real Estate
0.55%
Sensitive
37.48%
Communication Services
6.47%
Energy
3.73%
Industrials
1.92%
Information Technology
25.36%
Defensive
4.51%
Consumer Staples
1.75%
Health Care
1.52%
Utilities
1.24%
Not Classified
0.00%
Non Classified Equity
0.00%
As of July 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of July 31, 2026
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
97.82%
Less than 1 Year
97.82%
Intermediate
2.18%
1 to 3 Years
2.18%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of July 31, 2026
View Bond Maturity Exposure
Start Trial